Skip to content

Observational study Psychiatric Medical Unit.

Observational study on the change in regular psychometrics after (short) stay on the PMU, on somatic as well as psychiatric symptomatology.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26587
Enrollment
20
Registered
2010-12-10
Start date
2010-12-13
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

somatoform disorder (somatoforme stoornis, SOLK) anxiety disorder (angststoornis) depressive disorder (depressieve stoornis)

Interventions

The study is an observational study, no specific intervention will be studied, all of the interventions that are used on the PMU will be included, as needed in the individual treatment. Most common i
2. Medication: Most common are
antidepressants, anxiolytic med., antipsychotic med., benzodiazepines
3. Psychoeducation
4. Combination. The study is an observational study, so there will be no placebo/non-interventiongroup. In this study we only want to observe systematically if there's any change on regular standard
describe the trend that can be seen.

Sponsors

Atrium Medical Centre Heerlen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. > 18 yr; 2. Reffered by GP, medical specialist or psychologist to the "Soma en Psyche" centre of the Atrium MC; 3. Axis I disorder according to DSM IV; 4. "SOLK" / Somatoform disorder according to DSM IV; 5. Informed consent.

Exclusion criteria

Exclusion criteria: 1. < 18 yr; 2. Cognitive disorder / dementia according to DSM IV.

Design outcomes

Primary

MeasureTime frame
Change in somatic as well as psychiatric symptomatology.

Secondary

MeasureTime frame
Change in health related Quality of Life.

Contacts

Public ContactH.J.H. Bremer

Psychiater Atrium Medisch Centrum Parkstad Henri Dunantstraat 5

h.bremer@atriummc.nl045-5766490

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)